Coletiva de imprensa: detalhes sobre a vacina do Butantan - 12/01/2021
Date:
12/01/2021
O Instituto Butantan e o Governo de São Paulo informam que a vacina contra o coronavírus obteve 50,38% de eficácia global no estudo clínico desenvolvido no Brasil, além de proteção de 78% em casos leves e 100% contra casos moderados e graves da COVID-19. Todos os índices são superiores ao patamar de 50% exigido pela OMS (Organização Mundial de Saúde).
Os resultados foram submetidos a u...
See more details
Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Pandemics/prevention & control, Local Health Systems/organization & administration, Immunization Programs/organization & administration, Hospital Bed Capacity/statistics & numerical data, Clinical Trial, Phase III, Governmental Research Institutes, Brazilian Health Surveillance Agency, Vaccine Potency, Healthy Volunteers, COVID-19, Plano São Paulo, Coronavac, Instituto Butantan, Sinovac Biotech, Doria, João
Coletiva de imprensa: anúncios do Governo SP - 17/12/2020
Date:
17/12/2020
O Governador João Doria anunciou a chegada, nesta quinta-feira (17), de 2 milhões de doses prontas da vacina contra o coronavírus, a Coronavac, desenvolvida em parceria com o Instituto Butantan. Trata-se do maior lote de vacinas que chega à América do Sul até o momento.
“A pressa pela vacina é a pressa pela vida. Todos os brasileiros de bem têm pressa. São Paulo, reafirmo aqui, começar...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Brazilian Health Surveillance Agency, Holidays, Epidemiological Monitoring, Clinical Trial, Phase III, Immunization Programs/organization & administration, Public-Private Sector Partnerships/organization & administration, Risk Groups, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Local Health Systems/organization & administration, Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Masks, Social Isolation, Schools/standards, COVID-19, Plano São Paulo, Instituto Butantan, Coronavac, Sinovac Biotech
Coletiva do lançamento do Plano Nacional de operacionalização da vacina contra a COVID-19
Date:
16/12/2020
Durante o lançamento do Plano Nacional de Operacionalização da Vacina contra a Covid-19, na manhã desta quarta-feira (16/12), o ministro da Saúde, Eduardo Pazuello, reforçou o compromisso do Governo Federal em incorporar todas as vacinas contra o coronavírus que obtiverem o aval da Agência Nacional de Vigilância Sanitária (Anvisa). “Todas as vacinas produzidas no Brasil, ou pelo Butant...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Brazil/epidemiology, Risk Groups, Brazilian Health Surveillance Agency, Social Isolation, Masks, Clinical Trial, Phase III, Mobile Applications, Health Promotion, Local Health Systems/organization & administration, COVID-19, Pazuello, Eduardo, Astrazeneca, Vacina de Oxford, Fiocruz, Instituto Butantan, Sinovac Biotech, Coronavac
Ministério da Saúde apresenta balanço de ações contra a COVID-19
Date:
03/11/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Local Health Systems/organization & administration, Epidemiological Monitoring, Financial Resources in Health/economics, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Ventilators, Mechanical/supply & distribution, Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Personal Protective Equipment/supply & distribution, Primary Health Care/economics, Chloroquine/supply & distribution, Hydroxychloroquine/supply & distribution, Oseltamivir/supply & distribution, Brazil/epidemiology, Health Personnel/organization & administration, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Polymerase Chain Reaction/statistics & numerical data, Viral Vaccines/supply & distribution, Clinical Trial, Phase III, Immunization Programs/organization & administration, Risk Groups, COVID-19, Covax, Vacina de Oxford, Coronavac
